Trial Profile
A Preliminary Efficacy Study of Iguratimod in Patients With Sjögren's Syndrome
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 08 Jan 2019
Price :
$35
*
At a glance
- Drugs Iguratimod (Primary)
- Indications Sjogren's syndrome
- Focus Therapeutic Use
- 20 Jan 2017 New trial record